MedTrace Logo

Is MS14 Helpful in Schizophrenia?

NCT01083381 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2010-03-09

No results posted yet for this study

Summary

In this study we want to find out whether MS14 - a herbal drug- can help Schizophrenia patients or not.

Conditions

Interventions

DRUG

MS14

MS14 will be administered at an oral dose of 25-50 mg/kg/day in two divided doses for three months

DRUG

Risperidone

The treatment group receives Risperidone 2 mg per day in the beginning which is increased by 1 mg every day until reaching 4 mg/day; this regimen will be continued for three months.

Sponsors & Collaborators

  • Farzan Institute

    lead OTHER

Principal Investigators

  • Seyed Vahid Shariat · Department of Psychiatry and Mental Health Research Center, Iran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-10-31
Completion
2011-04-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083381 on ClinicalTrials.gov